Rourke J D, Shaw J S
Neuropeptides. 1984 Dec;5(1-3):85-8. doi: 10.1016/0143-4179(84)90033-7.
Attempts have been made to confirm reports that naloxonazine and Mr2034 are able to selectively antagonise morphine-induced analgesia and respiratory depression respectively. In the present studies these antagonists proved to be equi-effective against both the analgesic and respiratory depressant effects of morphine, suggesting that these two actions are mediated by a common receptor.